Researchers from the Wellcome Sanger Institute and partners found that genetic changes linked to neurofibromatosis type 1 (NF ...
Healx has dosed the first subject in the open-label Phase II INSPIRE-NF1 trial to assess the efficacy and safety of HLX-1502 ...
New findings question assumptions of cancer formation in individuals with the cancer-predisposition syndrome, ...
News Medical on MSN19h
Researchers challenge previous understanding of tumor growth in NF-1Despite what was previously thought, new research has shown that genetic changes alone cannot explain why and where tumors grow in those with genetic condition neurofibromatosis type 1 (NF-1).
Healx, an AI-enabled, clinical-stage biotech company dedicated to rare diseases, today announced the first patient has been dosed in INSPIRE-NF1, a Ph ...
The FDA has approved an oral, small molecule MEK inhibitor for adult and pediatric patients 2 years of age and older with ...
BuzzFeed News on MSN5d
Someone Asked If Adam Pearson Was Headed To The Circus Instead Of The BAFTAs, And He Had The Perfect Response To Their CrueltyA Different Man star Adam Pearson fired back at online trolls making insensitive remarks about him.
Healx has dosed the first patient in a Phase II trial assessing its lead pipeline candidate HLX-1502 in patients with neurofibromatosis type 1 (NF1), while the FDA approved SpringWorks Therapeutics’ ...
Actor Adam Pearson has been smacking down ableist commenters on X after one user called him “scary” due to his genetic ...
The US Food and Drug Administration has approved mirdametinib for the treatment of neurofibromatosis type 1 (NF1) in adults ...
Despite what was previously thought, new research has shown that genetic changes alone cannot explain why and where tumours grow in those with genetic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback